RNA Therapeutics Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

FDA Outlines Evidence Expectations for Individualized Therapies When Trials Aren’t Feasible

February 27, 2026

Arrowhead Secures First Approval with FDA Nod For FCS Therapy Redemplo Amid Ionis Clash

November 25, 2025

Detecting and Characterizing RNA Drug Candidates to Accelerate Therapeutic Development

January 28, 2026

Novartis Acquires Avidity Biosciences for Late-Stage Muscular Dystrophy Assets in $12B Deal

October 31, 2025

How Evf2 lncRNA Advances Research in Brain and Neurodevelopmental Disorders

December 11, 2025

Profiling Biology at Scale with DRUG-seq: From Mechanisms to Safety

November 14, 2025

Novel Long RNA Manufacturing Approaches for Advancing RNA Therapeutics

October 21, 2025

Accelerating RNA Therapeutics Discovery: From HELM-Based Design to Data-Driven Candidate Selection

Top 10 Biotech Trends for 2025

January 6, 2025

Tryngolza (Olezarsen) Becomes First FDA-Approved Drug for Familial Chylomicronemia Syndrome

January 3, 2025

Solutions for Vaccine Innovation and Gene Therapy: Unlocking the Power of RNA

December 17, 2024

RNA Therapeutics: Unlocking Data Insights for RNA Delivery Methods

World’s First RSV Vaccine + First Novel Treatment for ALS – Xtalks Life Science Podcast Ep. 109

FDA and CDC Update Guidelines Amid Omicron + Life Science Trends for 2022 – Xtalks Life Science Podcast Ep. 42

January 5, 2022

Key Trends in the Life Sciences to Look Forward to in 2022

December 22, 2021

Eli Lilly Pursues RNA Editing in New Partnership with ProQR

September 13, 2021